APA (7th ed.) Citation

H, S., J, Q., C, Y., G, Z., Y, H., X, X., . . . H, C. (2025). Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivo. Nature communications, 16(1), 11143. https://doi.org/10.1038/s41467-025-67654-z

Chicago Style (17th ed.) Citation

H, Shuai, et al. "Author Correction: An Orally Available Mpro/TMPRSS2 Bispecific Inhibitor with Potent Anti-coronavirus Efficacy in Vivo." Nature Communications 16, no. 1 (2025): 11143. https://doi.org/10.1038/s41467-025-67654-z.

MLA (9th ed.) Citation

H, Shuai, et al. "Author Correction: An Orally Available Mpro/TMPRSS2 Bispecific Inhibitor with Potent Anti-coronavirus Efficacy in Vivo." Nature Communications, vol. 16, no. 1, 2025, p. 11143, https://doi.org/10.1038/s41467-025-67654-z.